# Disruption of ATP Synthase Spatiotemporal Organization, Ca2+ Dynamics, and Contractile Function in Senescent Cardiomyocytes

**Authors:** Silke Morris, Nico Marx, Gonzalo Barrientos, Isidora Molina‐Riquelme, Frank Schmelter, Hugo E. Verdejo, Stefan Peischard, Guiscard Seebohm, Verónica Eisner, Karin B. Busch

PMC · DOI: 10.1111/acel.70388 · Aging Cell · 2026-01-28

## TL;DR

This study shows that aging heart cells have reduced energy production due to disrupted ATP synthase organization, leading to calcium imbalances and poor heart function.

## Contribution

The study reveals novel insights into how ATP synthase dysfunction in aging cardiomyocytes contributes to heart failure through disrupted energy and calcium dynamics.

## Key findings

- Senescent cardiomyocytes show increased ATP synthase mobility and cristae fenestrations, linked to reduced ATP production.
- Disrupted ATP metabolism correlates with dysregulated calcium dynamics and irregular heartbeats in aging cells.
- Enhanced ATP hydrolysis and mitochondrial instability contribute to energy deficits in senescent cardiomyocytes.

## Abstract

Heart disease is the leading cause of death in the elderly population. Age‐related heart failure is frequently associated with energy deficits in cardiomyocytes. These cells rely on their abundant, cristae‐rich mitochondria for ATP production. ATP synthase, localized along the cristae rims, is central to this process. It is presumed that its function is tightly bound to its spatial organization, but details remain unclear. Here, we explored the spatiotemporal organization of ATP synthase in senescent human iPSC‐derived CM in conjunction with its functions. We found changes in the stoichiometry of F1 and FO subunits in senescent CM. The ratio of FO‐SU c to F1‐SU β increased. The oligomeric organization of the complex was weakened. Using single‐molecule localization and tracking microscopy, we observed an increased enzyme mobility within cristae that displayed increased fenestrations. This coincided with decreased mitochondrial ATP level, increased ATP hydrolysis capacity, and a moderate increase in mitochondrial transition pore opening. Disturbed ATP production was correlated with dysregulated calcium dynamics, characterized by heightened spikes and slower cytosolic clearance. Consequently, senescent cardiomyocytes exhibited irregular autonomous and paced beating patterns. These findings indicate that, in senescent cardiomyocytes, functional decline is closely linked to disrupted ATP metabolism, driven by the aberrant organization, dynamics, and activity of ATP synthase within remodeled cristae.

Enhanced ATP hydrolysis, ΔΨm flickering, and destabilized ATP synthase dimers collectively reduce ATP availability in senescent cardiomyocytes. This energy deficit is associated with disrupted Ca2⁺ dynamics and contractility.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, Ppif (peptidylprolyl isomerase F (cyclophilin F)) [NCBI Gene 105675] {aka CyP-D, CyP-F, CypD, PPIase}, SLC8A1 (solute carrier family 8 member A1) [NCBI Gene 6546] {aka NCX1}, ACTN1 (actinin alpha 1) [NCBI Gene 87] {aka BDPLT15}, MYH14 (myosin heavy chain 14) [NCBI Gene 79784] {aka DFNA4, DFNA4A, FP17425, MHC16, MYH17, NMHC II-C}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, ATP5F1B (ATP synthase F1 subunit beta) [NCBI Gene 506] {aka ATP5B, ATPMB, ATPSB, DYT38, HEL-S-271, HUMOP2}, Atp5f1b (ATP synthase F1 subunit beta) [NCBI Gene 171374] {aka Atp5b}, Dnah8 (dynein, axonemal, heavy chain 8) [NCBI Gene 13417] {aka ATPase, Dnahc8, Hst6.7b, P1-Loop}, TLX2 (T cell leukemia homeobox 2) [NCBI Gene 3196] {aka HOX11L1, NCX}, Atp1b1 (ATPase, Na+/K+ transporting, beta 1 polypeptide) [NCBI Gene 11931] {aka Atp4b, Atpb, Atpb-1, NKbeta1}, PRSS3 (serine protease 3) [NCBI Gene 5646] {aka MTG, PRSS4, T9, TRY3, TRY4}, ATP5ME (ATP synthase membrane subunit e) [NCBI Gene 521] {aka ATP5I, ATP5K}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, Atp5if1 (ATP synthase inhibitory factor subunit 1) [NCBI Gene 25392] {aka Atpi, Atpif1, IF1PA}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, ATP5IF1 (ATP synthase inhibitory factor subunit 1) [NCBI Gene 93974] {aka ATPI, ATPIF1, ATPIP, IP}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}
- **Diseases:** NVCM (MESH:D007232), age (MESH:D019588), ATP deficiency (OMIM:614052), reduced energy metabolism (MESH:D001523), mitochondrial dysfunction (MESH:D028361), Heart disease (MESH:D006331), mitochondrial ATP deficiency (OMIM:604273), heart failure (MESH:D006333), CVDs (MESH:D002318), death (MESH:D003643)
- **Chemicals:** antimycin A (MESH:D000968), 5-bromo-2-deoxyuridine (MESH:D001973), HSA (MESH:D006585), thioglycerol (MESH:C009465), Doxorubicin (MESH:D004317), Calcein (MESH:C007740), F1-SU beta (-), GlutaMAX (MESH:C054122), phenol red (MESH:D010637), nitrogen (MESH:D009584), cobalt (MESH:D003035), SDS (MESH:D012967), lipid (MESH:D008055), Calcium (MESH:D002118), water (MESH:D014867), G418 (MESH:C010680), tungsten carbide (MESH:C002802), Alexa Fluor 555 (MESH:C000608607), Y-27632 (MESH:C108830), HEPES (MESH:D006531), SYBR Green (MESH:C098022), oil (MESH:D009821), polyacrylamide (MESH:C016679), Fura-Red (MESH:C082877), Tetramethylrhodamine-ethylester (MESH:C110932), doxycycline (MESH:D004318), PBS (MESH:D007854), CO2 (MESH:D002245), EGTA (MESH:D004533), sucrose (MESH:D013395), succinate (MESH:D019802), ATP (MESH:D000255), PVDF (MESH:C024865), Coomassie blue (MESH:C048139), oligomycin (MESH:D009840), proton (MESH:D011522), rotenone (MESH:D012402), digitonin (MESH:D004072), TS (MESH:D014316), CsA (MESH:D016572), Oxygen (MESH:D010100), C59 (MESH:C579131), streptomycin (MESH:D013307), Triton X-100 (MESH:D017830), Fluo-4 (MESH:C409648), FCCP (MESH:D002259), TES (MESH:C004551), penicillin (MESH:D010406)
- **Species:** Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** M Glycine for 10, F200C, C-95 C
- **Cell lines:** SUgamma-HaLo SFS.1 — Homo sapiens (Human), Fibrosarcoma, Cancer cell line (CVCL_C0D3), KAO717 — Homo sapiens (Human), Clear cell sarcoma of soft tissue, Cancer cell line (CVCL_W455), KA0637 — Homo sapiens (Human), Transformed cell line (CVCL_7297), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), fibroblasts — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0594), hiPS — Homo sapiens (Human), Hepatolenticular degeneration, Induced pluripotent stem cell (CVCL_Y517), SFS.1 — Homo sapiens (Human), Finite cell line (CVCL_0266)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12848789/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12848789/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC12848789/full.md

---
Source: https://tomesphere.com/paper/PMC12848789